Uptake, localization, and dosimetry of 111In and 201Tl in human testes

Journal of Nuclear Medicine

Volumn 45, Issue 1, 2004, Pages 138-146

  Nettleton, Jo S ^a,c   Lawson, Richard S ^a   Prescott, Mary C ^a   Morris, Ian D ^b  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c St Peter's House ^*  (United Kingdom)

Author keywords

Nuclear medicine; Radiation dosimetry; Testes

Indexed keywords

INDIUM CHLORIDE IN 111; RADIOISOTOPE; THALLIUM 201; DIAGNOSTIC AGENT; INDIUM; INDIUM CHLORIDE; RADIOPHARMACEUTICAL AGENT; THALLIUM; THALLIUM CHLORIDE;

ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DOSIMETRY; DRUG DISTRIBUTION; GERM CELL; HUMAN; HUMAN TISSUE; IN VIVO STUDY; ORCHIECTOMY; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; SPERMATOCYTE; TESTIS; AGED; BLOOD; CLINICAL TRIAL; COMPARATIVE STUDY; INTRAVENOUS DRUG ADMINISTRATION; MALE; METABOLISM; METHODOLOGY; RADIOMETRY; SCINTISCANNING; TISSUE DISTRIBUTION;

AGED; HUMANS; INDIUM; INJECTIONS, INTRAVENOUS; MALE; ORCHIECTOMY; RADIATION DOSAGE; RADIOMETRY; RADIOPHARMACEUTICALS; TESTIS; THALLIUM; TISSUE DISTRIBUTION;

EID: 1842592120     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Van-Reenen OR, Lotter MG, Minaar PC, du-Heyns A, Badenhorst PN, Pieters H. Radiation dose from human platelets labelled with indium-111. Br J Radiol. 1980;53:790-795.
2. 111In-labeled anticarcinoembryonic antigen monoclonal antibody: identification of carcinoembryonic antigen in normal germ cells. Cancer Res. 1986;46:6503-6508.
3. Murray JL, Rosenblum MG, Lamki L, et al. Clinical parameters related to optimal tumour localization of indium-111-labeled mouse antimelanoma monoclonal antibody ZME-018. J Nucl Med. 1987;28:25-33.
4. 201Tl. J Nucl Med. 1976;16:1070-1075.
5. Rao DV, Shepstone BJ, Wilkins HB, Howell RW. Kinetics and dosimetry of thallium-201 in human testes. J Nucl Med. 1995;36:607-609.
6. Debatin JF, Beytas EM. Indium 111 white blood cell imaging of epididymitis. Eur J Nucl Med. 1990;17:286-289.
7. Jonsson B-A. Biokinetics and Localization of Some Indium-111 Radiopharmaceuticals in Rats at the Macroscopic and Microscopic Level [PhD dissertation]. Lund, Sweden: Lund University; 1991.
8. 2 fragments evaluated from tissue distribution in rats. J Nucl Med. 1992;33:1654-1660.
9. Jonsson BA, Strand SE, Larsson BS. A quantitative autoradiographic study of the heterogeneous activity distribution of different indium-111-labeled radiopharmaceuticals in rat tissues. J Nucl Med. 1992;33:1825-1833.
10. Jonsson BA, Strand SE, Emanuelsson H, Larsson B. Tissue, cellular and subcellular distribution of indium radionuclides in the rat. In: Howell RW, Narra VR, Sastry KSR, Rao DV, eds. Biophysical Aspects of Auger Processes. Woodbury, NY: American Institute of Physics; 1992:249-272.
11. Jackson C, Jackson H, Bock M, Morris ID, Sharma HL. Metal radionuclides and the testis. Int J Radiat Biol. 1991;60:851-858.
12. Hoyes KP, Sharma HL, Jackson H, Hendry JH, Morris ID. Spermatogenic and mutagenic damage after paternal exposure to systemic indium-114m. Radiat Res. 1994;139:185-193.
13. Hoyes KP, Johnson C, Johnston RE, et al. Testicular toxicity of the transferrin binding radionuclide indium-114m in adult and neonatal rats. Reprod Toxicol. 1995;9:297-305.
14. Atkins H, Budinger T, Lebowitz E, et al. Thallium-201 for medical use. Part 3. Human distribution and physical imaging properties. J Nucl Med. 1977;18:133-140.
15. Hosain P, Hosain F. Revision of gonadal radiation dose to man from thallium-201. In: Proceedings of the Third International Radiopharmaceutical Dosimetry Symposium. Oak Ridge, TN; 1981:333-345.
16. Som P, Matsui K, Atkins HL, et al. Microautoradiographic studies on the cellular localization of radiothallium. Nucl Med. 1978;17:266-269.
17. ICRP Publication 53: Radiation dose to patients from radiopharmaceuticals. Ann ICRP. 1987;18:1-373.
18. 67Ga after intravenous administration. Int J Nucl Med Biol. 1981;8:211-212.
19. 201Tl in man. In: Oeff K, Schmidt H, eds. Nuklearmedizin und Biokybernetic [Nuclear Medicine and Biokinetics]. Vol 1. Berlin, Germany: Informationsdienste; 1978:385-389.
20. Hoyes KP, Morris ID, Hendry JH, Sharma HL. Transferrin mediated uptake of radionuclide by the testis. J Nucl Med. 1996;37:336-340.
21. Kuffler SW, Nicholls JG. From Neuron to Brain: A Cellular Approach to the Functions of the Nervous System. Sunderland, MA: Sinauer; 1977.
22. 199Tl as a potassium analog in scanning [abstract]. J Nucl Med. 1970;11:333.
23. Bianchi M. Cytotoxic insult to germinal tissue. Part 1. Testis; Part 2. Ovary. In: Potten CS, Hendry JH, eds. Cytotoxic Insult to Tissue: Effects on Cell Lineages. London, U.K.: Churchill Livingstone; 1983:258-328.
24. Oakberg EF. Mammalian gametogenesis and species comparisons in radiation responses of the gonads: effects of radiation on meiotic systems. International Atomic Energy Agency meeting; Vienna, Austria; 8-11 May, 1968.
25. Rao DV, Govelitz GF, Sastry KSR. Radiotoxicity of thallium-201 in mouse testes: inadequacy of conventional dosimetry. J Nucl Med. 1983;24:145-153.
26. Rao DV, Sastry KSR, Grimmond HE, et al. Cytotoxicity of some indium radiopharmaceuticals in mouse testes. J Nucl Med. 1988;29:375-384.
27. Rao DV, Narra VR, Howell RW, Lanka VK, Sastry KSR. Induction of sperm-head abnormalities by incorporated radionuclides: dependence on subcellular distribution, type of radiation dose rate and presence of radioprotectors. Radiat Res. 1991;125:89-97.
28. ICRP Publication 23: Report of the Task Group on Reference Man. Oxford, U.K.: Pergamon Press; 1975:182.
29. Loevinger R, Budinger TF, Watson EE. Primer For Absorbed Dose Calculations. New York, NY: Society of Nuclear Medicine; 1988.
30. ICRP Publication 80: Radiation doses to patients from radiopharmaceuticals: addendum 2 to ICRP Publication 53. Ann ICRP. 1998;28:1-126.
31. Addendum 1 to ICRP 53. Radiation doses to patients from radiopharmaceuticals. Ann ICRP. 1991;22:1-28.
32. Cox PH, Belfer AJ, van der Pompe WB. Thallium 201 chloride uptake in tumours, a possible complication in heart scintigraphy. Br J Radiol. 1976;49:767-768.
33. Beamish M, Brown E. The metabolism of transferrin bound indium-111 and iron-59 in the rat. Blood. 1974;43:693-701.
34. Beamish M, Brown E. A comparison of the behaviour of indium-111 and iron-59 labelled transferrin on incubation with human and rat reticulocytes. Blood. 1974;43:703-711.
35. 111In across a membrane: role of plasma binding and concentration gradients. Nucl Med Commun. 1992;13:349-356.
36. Hoyes KP, Morris ID. Environmental radiation and male reproduction. Int J Androl. 1996;19:199-204.
37. Humm JL, Howell RW, Rao DV. Dosimetry of Auger electron emitting radionuclides: Report No. 3 of the AAPM Nuclear Medicine Task Group No. 6. Med Phys. 1994;21:1901-1915.
38. Rao DV, Mylavarapu VB, Sastry KSR, Howell RW. Internal Auger emitters: effects on spermatogenesis and oogenesis in mice. In: Baverstock KF, Charlton DE, eds. DNA Damage by Auger Emitters. London, U.K.: Taylor and Francis 1988:15-26.
39. Johnson L, Petty CS, Neaves WB. A comparative study of the daily sperm production and testicular components in humans and rats. Biol Reprod. 1980;22:1233-1243.
40. Nistal M, Mora JCD, Paniagua R. Classification of several types of maturational arrest of spermatogonia according to Sertoli cell morphology: an approach to aetiology. Int J Androl. 1998;21:317-326.
41. Sayle BA, Fawcett HD, Wilkey DJ, Cierney G. Indium-111 chloride imaging in the detection of infected prostheses. J Nucl Med. 1985;26:718-721.
42. Sailer B, Jost L, Erikson K, Tajiran M, Evenson D. Effects of x-irradiation on mouse testicular cells and sperm chromatin structure. Environ Molec Mutagen. 1995;25:23-30.